Name: Pfizer to temporarily reduce Covid vaccine deliveries to Europe
Brand: cnbc.com
SKU: cnbc-com-485
Availability: OnlineOnly

critic

Pfizer to temporarily reduce Covid vaccine deliveries to Europe

preview

Key PointsIn this articleLONDON — will temporarily reduce the number of doses of its coronavirus vaccine being delivered to Europe.The Norwegian Institute of Public Health received a message from Pfizer "little before 10 o'clock" Friday, according to a translation of a statement released by the authority shortly afterwards. NIPH's statement said that deliveries of the Pfizer- vaccine would be reduced from next week "and for a period ahead.""We were predicted 43,875 vaccine doses from Pfizer in week 3. Now it seems that we get 36,075 doses," the statement said.NIPH said the temporary reduction in deliveries was "in connection with an upgrade of production capacity." "The temporary reduction will affect all European countries," it added.Pfizer later confirmed the disruption to deliveries in a statement. "As part of the normal productivity improvements to increase capacity, we must make modifications to the process and facility that will require additional regulatory approvals," it explained.Pfizer added that while this would "temporarily impact shipments in late January to early February, it will provide a significant increase in doses available for patients in late February and March."&nbsp;&nbsp;In the meantime, Pfizer said that there may be "fluctuations in orders and shipping schedules" at its Puurs facility in Belgium "in the immediate future."Pfizer CEO Albert Bourla told CNBC's "Squawk Box" on Tuesday that he felt confident that it could "increase dramatically" production of the vaccine this year with a goal of manufacturing up to 2 billion doses.Bourla also said Pfizer currently had more doses of its vaccine available than were being used.The European Union said last week that it was of the Pfizer-BioNTech vaccine.Ursula von der Leyen, president of the European Commission, said the agreement would allow the EU to purchase another 300 million doses to its existing stock. The EU's executive arm has already been criticized for not buying more of the vaccine.Rollouts have been slow across many EU nations, including France, Germany and the Netherlands, and this latest news will likely weigh on inoculation programs in those counties. Canada has also confirmed that its shipments will be delayed, but said it's hopeful that it won't impact its vaccination program.Pfizer CEO Albert Bourla on Covid vaccine manufacturing outlook

Key PointsIn this articleLONDON — will temporarily reduce the number of doses of its coronavirus vaccine being delivered to Europe.The Norwegian Institute of Public Health received a message from Pfizer "little before 10 o'clock" Friday, according to a translation of a statement released by the authority shortly afterwards. NIPH's statement said that deliveries of the Pfizer- vaccine would be reduced from next week "and for a period ahead.""We were predicted 43,875 vaccine doses from Pfizer in week 3. Now it seems that we get 36,075 doses," the statement said.NIPH said the temporary...

public

Vicky McKeever

cnbc.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Pfizer to temporarily reduce Covid vaccine deliveries to Europe

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS